Your cart is currently empty!
Partner With ORF
Partner with us to access cutting-edge growth factors engineered to transition seamlessly from research to large-scale production.
Industry Leaders We Serve
Protein Research Innovators
Researchers working in fields like assay development, structural biology, or exploratory science rely on stand-alone, high-purity proteins to deliver accurate and reproducible results. Their work demands uncompromised bioactivity, batch-to-batch consistency, and technical data that supports rigorous validation, ensuring confidence in every experiment, from initial tests to peer-reviewed publication.
Biotech Pioneers
Biotech startups, diagnostics developers, and academic labs advancing product pipelines often require a dependable source of proteins or biologics. They value flexible, scalable production that can adapt to project evolution, formulation tweaks, or growing demand, paired with reliable supply logistics that won’t disrupt timelines or innovation milestones.
Drug Discovery Teams
Pharmaceutical companies and therapeutic developers seek advanced protein engineering and synthetic biology tools to create differentiated biologic candidates. They rely on early-stage manufacturing insight, functional prototyping, and iterative process design to fine-tune drug candidates, turning discovery into validated, scalable therapeutics for complex clinical challenges.
OUR COMPANY
Committed to Scientific Excellence and Service
We work closely with our partners to commercialize best-in-class human growth factors, always ensuring that our products meet the highest quality standards. From the initial concept to final delivery, we are committed to maintaining open channels and providing exceptional support, ensuring your success in biopharma development.
OUR EXPERIENCE
Amplifying Discovery Outcomes
We offer high-value licensing and partnering opportunities with industry leaders and biopharma innovators to commercialize breakthrough biologics. Our expertise in protein engineering, advanced expression systems, and scalable production ensures the successful translation of discoveries into impactful solutions.
Areas of Interest
Biologics offer transformative potential across a broad spectrum of diseases and conditions. Produced through advanced recombinant and expression technologies, they can be tailored for use in therapeutic areas such as immunology, oncology, neuroscience, wound healing and rare diseases. These versatile molecules are paving the way for new possibilities in research and therapeutics, providing scalable solutions for conditions that currently lack effective therapies.
Neuroscience
Oncology
Wound Healing
Autoimmune Diseases
We support the neuroscience field by providing advanced biologics that enable groundbreaking research and therapies for neurodegenerative diseases, brain injuries, and spinal cord regeneration. By offering high-quality, reproducible biologic formulations and data-driven characterization, we help researchers and clinicians unlock new approaches to treating conditions like Alzheimer’s, Parkinson’s, and stroke.
We partner with oncology researchers and biopharma companies to advance cancer treatments using our high-quality biologics, including antibody drug conjugates and recombinant protein therapeutics. Our expertise in immuno-oncology—featuring next-generation antibody drug conjugates and bispecific antibody therapies—enables more targeted, effective treatments with fewer side effects. We support the development of personalized cancer therapies that have the potential to transform patient outcomes.
We partner with researchers and clinicians to advance wound healing therapies using our high-quality biologics, including recombinant growth factors, extracellular matrix proteins, and engineered peptide scaffolds. Our expertise in regenerative medicine—featuring next-generation growth factor cocktails and bioactive scaffolds—enables more targeted, effective repair with reduced scarring and infection risk. We support the development of personalized wound healing solutions that have the potential to transform patient outcomes.
We partner with researchers to explore new therapies for autoimmune diseases by offering high-quality biologics that restore immune balance and promote tissue repair. Through immune-modulating proteins—such as monoclonal antibodies and receptor agonists—we enable advancements in treating conditions like rheumatoid arthritis, lupus, and multiple sclerosis, helping to reduce inflammation and prevent tissue damage caused by overactive immune responses.